Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2028

1.
2.

[Role of kidney injury molecule-1 (KIM-1) for inhospital event risk assessment after coronary artery bypass surgery].

Shafranskaia KS, Uchasova EG, Sumin DA, Krivoshapova KE, Kalaeva VV, Evseeva MV, Karetnikova VN, Barbarash OL, Barbarash LS.

Kardiologiia. 2014;54(9):4-10. Russian.

PMID:
25702396
3.

Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials.

Le Page S, Bejan-Angoulvant T, Angoulvant D, Prunier F.

Basic Res Cardiol. 2015 Mar;110(2):11. doi: 10.1007/s00395-015-0467-8. Epub 2015 Feb 5.

PMID:
25653117
4.

Temporal expression of galectin-3 following myocardial infarction.

Milner TD, Viner AC, MacKinnon AC, Sethi T, Flapan AD.

Acta Cardiol. 2014 Dec;69(6):595-602.

PMID:
25643429
5.

Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women.

Benn M, Voss SS, Holmegard HN, Jensen GB, Tybjærg-Hansen A, Nordestgaard BG.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):471-7. doi: 10.1161/ATVBAHA.114.304821. Epub 2014 Dec 30.

PMID:
25550203
6.

Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris.

Pedersen ER, Tuseth N, Eussen SJ, Ueland PM, Strand E, Svingen GF, Midttun Ø, Meyer K, Mellgren G, Ulvik A, Nordrehaug JE, Nilsen DW, Nygård O.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):455-62. doi: 10.1161/ATVBAHA.114.304674. Epub 2014 Dec 18.

PMID:
25524770
7.

Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.

Taqueti VR, Everett BM, Murthy VL, Gaber M, Foster CR, Hainer J, Blankstein R, Dorbala S, Di Carli MF.

Circulation. 2015 Feb 10;131(6):528-35. doi: 10.1161/CIRCULATIONAHA.114.009716. Epub 2014 Dec 5.

PMID:
25480813
8.

Outcomes after percutaneous coronary intervention with stents in patients treated with thoracic external beam radiation for cancer.

Liang JJ, Sio TT, Slusser JP, Lennon RJ, Miller RC, Sandhu G, Prasad A.

JACC Cardiovasc Interv. 2014 Dec;7(12):1412-20. doi: 10.1016/j.jcin.2014.05.035. Epub 2014 Nov 12.

PMID:
25459527
9.

Various admission glucose cut-offs for prognostication and for therapeutic threshold in acute myocardial infarction.

Koracevic GP.

Am J Emerg Med. 2015 Jan;33(1):108-9. doi: 10.1016/j.ajem.2014.09.046. Epub 2014 Oct 14. No abstract available.

PMID:
25445867
10.

[Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality].

Loforte A, Pilato E, Martin Suarez S, Folesani G, Jafrancesco G, Castrovinci S, Cefarelli M, Potena L, Magnani G, Grigioni F, Caramelli F, Frascaroli G, Di Bartolomeo R, Marinelli G.

G Ital Cardiol (Rome). 2014 Oct;15(10):577-85. doi: 10.1714/1672.18312. Italian.

PMID:
25424022
11.

HDL cholesterol efflux capacity and incident cardiovascular events.

Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, Neeland IJ, Yuhanna IS, Rader DR, de Lemos JA, Shaul PW.

N Engl J Med. 2014 Dec 18;371(25):2383-93. doi: 10.1056/NEJMoa1409065. Epub 2014 Nov 18.

PMID:
25404125
12.

Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease.

Pechlaner R, Willeit P, Summerer M, Santer P, Egger G, Kronenberg F, Demetz E, Weiss G, Tsimikas S, Witztum JL, Willeit K, Iglseder B, Paulweber B, Kedenko L, Haun M, Meisinger C, Gieger C, Müller-Nurasyid M, Peters A, Willeit J, Kiechl S.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):229-36. doi: 10.1161/ATVBAHA.114.304729. Epub 2014 Oct 30.

PMID:
25359861
13.

Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Liu KD, Yang W, Go AS, Anderson AH, Feldman HI, Fischer MJ, He J, Kallem RR, Kusek JW, Master SR, Miller ER 3rd, Rosas SE, Steigerwalt S, Tao K, Weir MR, Hsu CY; CRIC Study Investigators.

Am J Kidney Dis. 2015 Feb;65(2):267-74. doi: 10.1053/j.ajkd.2014.07.025. Epub 2014 Oct 11.

PMID:
25311702
14.

Myocardial perfusion imaging in emergency department patients with negative cardiac biomarkers: yield for detecting ischemia, short-term events, and impact of downstream revascularization on mortality.

Cremer PC, Khalaf S, Agarwal S, Mayer-Sabik E, Ellis SG, Menon V, Cerqueira MD, Jaber WA.

Circ Cardiovasc Imaging. 2014 Nov;7(6):912-9. doi: 10.1161/CIRCIMAGING.114.002401. Epub 2014 Oct 1.

PMID:
25273569
15.

Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.

Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, Lopes RD, Green CL, Lincoff AM, Armstrong PW, Roe MT.

Am Heart J. 2014 Oct;168(4):503-511.e2. doi: 10.1016/j.ahj.2014.06.008. Epub 2014 Jun 9.

PMID:
25262260
16.

Evaluation of prognostic scale Thrombolysis In Myocardial Infarction and Killip. An ST-elevation myocardial infarction new scale.

García-Paredes T, Aguilar-Alonso E, Arboleda-Sánchez JA, Vera-Almazán A, Arias-Verdú MD, Oléa-Jiménez V, Fuset-Cabanes MP, Sánchez-Cantalejo E, Rivera-Fernández R.

Am J Emerg Med. 2014 Nov;32(11):1364-9. doi: 10.1016/j.ajem.2014.08.026. Epub 2014 Aug 21.

PMID:
25224025
17.

Angiotensin II type 1 receptor expression in astrocytes is upregulated leading to increased mortality in mice with myocardial infarction-induced heart failure.

Isegawa K, Hirooka Y, Katsuki M, Kishi T, Sunagawa K.

Am J Physiol Heart Circ Physiol. 2014 Nov 15;307(10):H1448-55. doi: 10.1152/ajpheart.00462.2014. Epub 2014 Sep 12.

PMID:
25217656
18.

Prognostic value of red blood cell distribution width in prediction of in-hospital mortality in patients with acute myocardial infarction.

Sangoi MB, Guarda Ndos S, Rödel AP, Zorzo P, Borges PO, Cargnin LP, De Carvalho JA, Premaor MO, Moresco RN.

Clin Lab. 2014;60(8):1351-6.

PMID:
25185421
19.

Novel biomarkers in the diagnosis of acute coronary syndromes: the role of circulating miRNAs.

Rognoni A, Cavallino C, Lupi A, Secco GG, Veia A, Bacchini S, Rosso R, Rametta F, Bongo AS.

Expert Rev Cardiovasc Ther. 2014 Sep;12(9):1119-24. doi: 10.1586/14779072.2014.953483. Review.

PMID:
25160996
20.

The emerging role of microRNAs in cardiovascular disease.

Maegdefessel L.

J Intern Med. 2014 Dec;276(6):633-44. doi: 10.1111/joim.12298. Epub 2014 Sep 23. Review.

PMID:
25160930
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk